✨
AI Summary
- State of rare disease R&D and genomics.
- Challenges in the biopharma industry's focus on rare diseases.
- Oxford-Harrington Rare Disease Center drives innovation.
Guests on This Episode
MW
Matthew Wood
1 podcast appearance